However, the use of fluoxetine to favor GluN2A-associated structural and functional synaptic changes in nondepressed epileptic patients or even in preventing oxidative stress associated to neurological disorders is open to discussion and additional experimental work (Zhu et al., 2018). Here, GRIN2A is linked to nervous system disorder.